Paired tumor biopsy analysis and safety data from a pilot study evaluating Tremelimumab - a monoclonal antibody against CTLA-4 - in combination with ablative therapy in patients with hepatocellular carcinoma (HCC)

Detalles Bibliográficos
Autores principales: Duffy, Austin, Kerkar, Sid P, Kleiner, David E, Ulahannan, Susanna, Kurtoglu, Metin, Rusher, Oxana, Fioravanti, Suzanne, Walker, Melissa, Figg, William D, Compton, Kathryn, Venkatesan, Aradhana, Abi-Jaoudeh, Nadine, Wood, Brad, Greten, Tim F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288787/
http://dx.doi.org/10.1186/2051-1426-2-S3-P98

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288787/
http://dx.doi.org/10.1186/2051-1426-2-S3-P98

Ejemplares similares